Skip to content

Project PREVAM : Prospective Comparison of Capsule Endoscopy Pillcam II™ Versus Colonoscopy

Prospective Comparison of Capsule Endoscopy Pillcam II™ Versus Colonoscopy for the Detection of Adenomatous Polyps and Cancer in a High Risk Population

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01184781
Enrollment
50
Registered
2010-08-19
Start date
2010-08-31
Completion date
2013-11-30
Last updated
2023-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomatous Polyps, Cancer

Brief summary

The aim of the study is to perform a prospective, multicenter research comparing capsule endoscopy with the video colonoscopy in the detection of the adenomatous polyps and cancer specifically in a high risk population (sensibility, specificity, NPV, PPV and diagnostic accuracy). The investigators will used the Pillcam II™ colon capsule (second generation) and a high resolution colonoscope (with high definition). Both procedures will be perform in the same day with an adapted bowel preparation.

Interventions

DEVICEComparison of capsule endoscopy Pillcam II™ versus colonoscopy

On the same patient, we compare both methods (video-colonoscopy vs capsule endoscopy)

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years old * Patient with 40 years old and first degree relative affected by colo rectal cancer at age ≥ 60 ans * Patient with 40 years old or ten years before the age at affected disease in case or first deree relative colo rectal cancer before 60 years old. * Fecal occult blood test positive * Personal history of adenomatous polyps * Personnal history of acromegaly * Patient with social insurance * Persons already participating in another clinical trial.. * Signature of informed consent

Exclusion criteria

* Pregnancy or breast feeding woman * Déficience mentale du sujet rendant sa participation à l'essai impossible * Pacemaker or all electronic devices implanted * Patient with swallowing disorder, or digestive stricture know or suspected by the investigator * Previous history of intestinal surgery, radiotherapy or inflammatory bowel disease * Previous history of polyadenomatous congenital disease, Lynch syndrome * Intolerance with dompéridon and/or bisacodyl * Intolerance with oral intake of NaP, polyethylen glycol (PEG) or macrogol * Colonoscopy contre indication for anesthesiologic reasons

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants with Adverse Events as a Measure of Safety and Tolerability7 daysThe investigators want to know if the capsule endoscopie is more or less effective than colonoscopy to detect lesion or abdominal cancer.

Secondary

MeasureTime frameDescription
Pain Scores on the Visual Analog Scale7 daysPresence of at least one polyp at capsule endoscopy and colonoscopy with both operators unaware of each other's findings until completion of the procedures. Comparison of the different class of size for all polyps Comparison of Kudo and Paris classification of the polyps at endoscopy capsule and colonoscopy Tolerance, pain and discomfort between the both procedure Acceptability of both procedure at day 1 and day 7 Accuracy of the localization of the polyp or the lesion at the capsule endosocpy comparated with the colonoscopy topography (Gold standard).

Countries

France, Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026